SURVEY: How do you treat your SOC patients with acne?
Shades for the treatment of acne in SOC patients
In the Skin of Color 2021 update, Andrew Alexis, MD, MPH, presented the subtle distinctions in treating colored skin in acne patients.
The DermTech TRUST study is published
Data from DermTech’s Pigmented Lesion Assay has been published in SKIN: The Journal of Cutaneous Medicine showing the results of its melanoma detection.
FDA approves halobetasol propionate foam for plaque psoriasis in adolescents
The FDA has approved halobetasol propionate 0.05% foam (Lexette; Mayne Pharma), a potent topical corticosteroid, for the treatment of plaque psoriasis in adolescent patients.
Verrica Pharmaceuticals receives response from the FDA
Verrica Pharmaceuticals has received a comprehensive response letter from the FDA identifying deficiencies in a VP-102 manufacturing facility.
Dermatology Times medical editor weighs in on black box warning for JAK inhibitors
In this exclusive video interview, Zoe Diana Draelos, MD, editor of the Dermatology Times, takes a look at the recent Black Box Warning issued by the FDA against certain JAK inhibitors.
FDA approves ruxolitinib for atopic dermatitis
Incyte announced that the FDA has approved its topical selective Janus kinase (JAK) 1 / JAK2 ruxolitinib (Opzelura) inhibitor for the treatment of mild to moderate atopic dermatitis.
FDA accepts priority review for melanoma treatment
Bristol Myers Squibb announced that the FDA has accepted the Biologic License Application (BLA) for relatlimab and nivolumab, a fixed-dose combination therapy for unresectable or metastatic melanoma.
Pipeline Updates in Melanoma
Possible treatments for melanoma have had several newsworthy events since July 2021.
What happened in the Skin of Color 2021 update?
Check out all the latest news from the Skin of Color 2021 update.
FDA announces action on sunscreens
The FDA has announced measures to improve the quality, safety and effectiveness of sunscreens.
Rejuvenating laser causes acne-like reaction Agminate
A recent case report emphasizes the importance of caution when using fractional laser resurfacing in patients with active or previous acne.
Pipeline of Promise for atopic dermatitis
A constant stream of new therapeutic agents is now navigating the atopic dermatitis pipeline.
The ordinary patient: September 23
This week’s edition of The ordinary patient features stories about Botox stigma, treating patients’ skin of color, laser hair removal, skin care microdosing, and more.
Lab markers help assess atopic dermatitis
Investigators added that the meaning of each lab marker depends on the drug used for treatment.
The Skin Connection: Episode 31 – Molecular Targeting of Psoriasis Biologics
This episode highlights the results of an investigative study exploring molecular targeting of biologics for psoriasis, the IL-17 class of drugs, how bimekizumab is different, and more.
Treat palmoplantar psoriasis with a chemical peel and gentian violet
Even with the patient’s reluctance, treating PPP with gentian violet and chemical peels might help patients avoid biologics.
New frontiers open for AD, Eczema Solutions
NEA’s Eczema Expo highlights new drugs, steroid withdrawal and alternative therapies.
Pointers With Dr Portela: Responding to Cystic Acne with Cassandra Bankson
In this week’s pointers with Dr. Portela, 208SkinDoc and Cassandra Bankson, medical esthetician and skin advocate, respond to TikToks cystic acne and offer feedback.
Recognize and treat rosacea in colored skin
Hilary Baldwin, MD, explained how to recognize, diagnose and treat rosacea in patients with colored skin during the Skin of Color 2021 update.